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ABSTRACT
FAILURE OF OPIOIDS TO MODIFY NORADRENERGIC 
NEURONAL RECOVERY FROM A DORSAL BUNDLE LESION 
IN NEONATAL RATS 
by
Ellen Kunkel Bagden
Morphine and exogenous opioid peptides alter the 
development of central noradrenergic neurons damaged by 
neonatal treatment with the neurotoxin 6-hydroxydopa. 
Transection of the dorsal noradrenergic bundle (DNB) in 
neonatal rats produces nearly the same alteration in the 
developmental pattern. It was of interest to determine 
whether morphine or an exogenous opioid peptide (met- 
enkephalin) was able to modify the recovery of noradrenergic 
neurons after neonatal surgical transection of the DNB. 
Neonatal rats were divided into two groups. Both groups 
received saline (0.85%) or naloxone (2.0 mg/kg) by the 
intraperitoneal (i.p.) route. In the first group the 
animals received an additional i.p. injection of either 
saline or morphine sulfate (3.33 mg/kg). The second group 
received an intraventricular injection of either saline, 
morphine (10 ug/5 pi), or methionine-enkephalin (25 pg/
5 yl) ten minutes after the i.p. injection. Half the 
animals in these groups then received a DNB lesion, made 
with a blade 3mm (depth) by 5mm (width) at the level of 
the colliculi. At 6 weeks brains were removed for assay 
of norepinephrine (NE) content by a fluorometric method, 
and for determination of the rate of H-NE uptake, in 
order to assess noradrenergic fiber number. It was found 
that in the cerebellum both the H-NE uptake rate and NE 
content were significantly elevated by approximately 75% 
in the animals that received the lesion. The recovery in 
the anterior cortex (39%) was significantly greater than 
in the posterior cortex (27%), while recovery in the 
hippocampus (21%) was the least. This indicates a regional 
difference in recovery in the more distal projections of 
the DNB. Within the lesion group, however, there was no 
alteration in H-NE uptake rate nor NE content in any of 
the above regions with any of the drug treatments.
Therefore, none of the drug treatments effectively altered 
the recovery from surgical transection of the DNB. It is 
suggested that opioids are capable of modifying neurotoxin 
damage per se, but not capable of modifying regeneration 
of noradrenergic neurons.
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Chapter I 
Historical Review
A. Introduction
The noradrenergic (HA) neuronal pathways in the 
central nervous system (CHS) have been well mapped and are 
known to extensively innervate virtually all major structures 
of the brain and spinal cord. One of the most common means 
of studying the distribution of this fiber network is the 
destructive elimination of portions of the pathways, 
followed by subsequent histochemical/biochemical mapping 
in the experimental and control groups. Removal of HA 
fibers can be brought about by administration of relatively 
selective neurotoxins such as 6-hydroxydopamine (6-OHDA) or 
6-hydroxydopa (6-0HD0PA), or by mechanical transection of 
the fiber bundles.
In order to gain insights into the ontogenic development 
of the above system, the indicated procedures are often 
carried out in immature animals. Because of the growing 
body of evidence that opioids interact with the HA system
in a variety of ways, it is considered to be of value to
determine how opioids might alter the developmental 
recovery of the HA system after a mechanical injury to one 
of the major fiber bundles.
B. Projections of the Locus Coeruleus
The locus coeruleus, a compact pontine nucleus located
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in the central gray of the isthmus, is comprised of about 
1500 cells which project axons throughout the CNS. The 
largest fiber projection of this nucleus is the dorsal 
noradrenergic bundle (DNB), which transmits axons to 
many forebrain regions. This compact bundle joins the 
medial forebrain bundle, and ascends rostrally in the 
brain to the genu of the corpus callosum, whereupon it 
diverges into a highly collateralized network (Moore and 
Bloom, 1979). The fibers of the DNB terminate in the 
cerebral cortex, hippocampus, thalamus, geniculate bodies, 
colliculi, habenula, some dorsal hypothalamic nuclei, and 
olfactory bulb (see Jacobowitz, 1978). The locus coeruleus 
also provides fibers which innervate virtually all segments 
of the spinal cord, distributing widely to both dorsal and 
ventral horns. Projections from the coeruleus have 
additionally been demonstrated in the brainstem, 
predominantly to the sensory nuclei. A third area to which 
the locus coeruleus projects is the cerebellum. In this 
brain region a sparse input to the granule cell layer is 
noted, along with an extensive innervation of the Purkinje 
cells and molecular layer (Moore and Bloom, 1979).
In the rat the cells of the locus coeruleus 
differentiate between fetal days 10 and 13. The fiber 
connections to all the target areas of the nucleus have 
been made by birth (Lauder and Bloom, 1974), although the 
target areas per se may develop later. Groups of neurons 
in the locus coeruleus are known to be divergent, i.e., a
single neuron projects axons to two or more regions in the 
CNS, such as to the cerebellum and spinal cord; or the 
frontal cortex and cerebellum; or the neocortex and 
hippocampus; etc. (Steindler, 1981; Room et al., 1981; 
and Ader et al., 1980). Steindler (1981) estimated that 
in mice 6% of the locus coeruleus cells that project to the 
neocortex also provide collateral fibers to the cerebellum. 
Conversely, 61% of the cells that project to the cerebellum 
were found to have collaterals to the neocortex. The fiber 
projections to the cerebral cortex from the nucleus are of 
two types. The most common fiber type innervates a 
restricted region, while the other innervation is wide­
spread to various areas of the cortex (Nagai et al., 1981).
C. Destruction of the Noradrenergic Fiber Pathways
Several methods are available to alter the pattern 
of distribution of the fiber projections from the locus 
coeruleus. Administration of 6-OHDA or 6-OHDOPA to neonatal 
rats during the first two weeks after birth results in de­
generation of NA fibers. This is followed by a permanent 
hyperinnervation by central NA neurons in the pons-medulla, 
mesencephalon, and cerebellum, when treatment is prior to the 
fourth postnatal day. In contrast the NA input to forebrain 
regions remains permanently reduced after such treatment 
(Breese and Traylor, 1970; Jonsson et al., 1974; Zieher 
and Jaim-Etchevery, 1975; Pappas and Sobrian, 1972; 
and Kostrzewa and Garey, 1976). The principal nucleus
involved in this alteration of NA inputs is the locus 
coeruleus, and it is this nucleus that is associated with 
the major portion of NA sprouting or hyperinnervation 
(Schmidt and Bhatnagar, 1979). The result of neonatal 
neurotoxin treatment is a reduction in NA input to the 
forebrain regions accompanied by an elevation in the NA 
input to the hindbrain regions.
Neonatal surgical transection of the DNB produces 
nearly the same alteration in developmental pattern as 
neurotoxin treatment. Kostrzewa et al. (1985) found that 
a brainstem lesion/ encompassing both dorsal noradrenergic 
bundles, in neonatal rats between postnatal days 1 and 7, 
produces significant alterations in the adult pattern of 
NA fiber distribution. As a result of this neonatal lesion 
animals develop into adulthood with a significant decrease 
in norepinephrine (NE) content and fluorescent NA fiber 
density (with the glyoxylic acid technique) in the cerebral 
cortex and hippocampus, but with an increase in these 
parameters in the pons-medulla and cerebellum. Jonsson 
and Sachs (1982), using either a bilateral lesion as above 
or a unilateral transection of the DNB, noted similar 
developmental changes. The animals as adults have decreas- 
ed levels of NE, H-NE uptake, and fluorescent fiber number 
in the cerebral cortex, and a corresponding increase in 
these parameters in the mesencephalon, pons-medulla, and 
cerebellum.
These alterations in NA input, demonstrated with neuro­
toxin treatment and transection of the DNB, have been 
explained by Jonsson and Sachs (1962) and Jonsson and 
Hallman (198 2b) as due to the so-called Mpruning effect." 
In this theory neurons are said to be programmed to form a 
defined quantity of nerve terminals. If one branch is 
prevented from growing then a compensatory outgrowth will 
take place in the intact branches proximal to the lesion. 
As stated previously the pattern of recovery is almost 
identical for neurotoxin treated and surgically axotomized 
animals, but the changes are less pronounced in surgically 
altered animals. However, the method of denervation of 
each of these techniques is uniquely distinct. The 
surgical lesion affects only the DNB, while neurotoxin 
treatment results in at least a partial denervation of 
virtually all NA terminal areas. The surgical lesion, by 
damaging the major ascending axonal fibers, results in 
degeneration distal to the cut. The brainstem lesion also 
severs blood vessels, other nerve fibers, and damages the 
parenchymal tissue, while the neurotoxin destroys princi­
pally NA fibers.
D. Opioids
Recent evidence indicates that opioid peptide- 
containing neurons are an integral part of the CNS. These 
neurons contain as neuromodulators or neurotransmitters 
endogenous peptides, which are part of the opioid families 
of enkephalins, endorphins, and dynorphins. The neurons
have been mapped by immunohistochemistry and their respective 
nuclei and patterns of distribution are different from each 
other (Cuello, 1983 and Bloom, 1983).
The enkephalins are formed from enzymatic cleavage of 
a prohormone. Methionine-enkephalin (met-enkephalin), 
specifically, is a pentapeptide (Tyr-Gly-Gly-Phe-Met) 
formed by cleavage of proenkephalin-A (Morley, 1983). 
Enkephalins can be released by electrical or high potassium 
induced stimulation. These peptides are inactivated by the 
cerebral peptidases, aminopeptidase and enkephalinase 
(Hughes, 1983). The concentration of met-enkephalin is 
higher throughout the brain than that of the other 
enkephalin, leucine-enkephalin. The striatum has the 
highest levels of met-enkephalin. Of the areas under 
study high levels of met-enkephalin are found in the 
pons-medulla, lower levels are detected in the cortex and 
hippocampus, and the lowest levels are present in the cere­
bellum (Cuello, 1983 and Yang et al., 1977). Enkephalin- 
immunoreactive nerve fibers are known to innervate the 
source nuclei of all three major monoamine systems: the
substantia nigra, the locus coeruleus, and the raphe 
nuclei (Bloom, 1983).
Tsang et al. (1982) found that the highest postnatal 
developing levels of enkephalin and its binding sites were 
obtained within the first week for the cerebellum, during 
the second week in the brainstem, and in the third week 
within the forebrain and cerebral cortex.
Recently the interaction of the enkephalinergic neurons 
with NA neurons has been studied. Bloom (1983) noted that 
enkephalin-immunoreactive fibers innervate the locus 
coeruleus and the presence of opioid receptors in the 
coeruleus has been known for several years. Enkephalin- 
containing fibers have also been identified in all brain 
regions to which the locus coeruleus projects.
E. Opioids in Combination with Neurotoxins
The locus coeruleus perikarya are known to receive 
several inputs. The enkephalinergic input described earlier 
is considered to be an inhibitory one (Aghajanian and 
Cedarbaum, 1979). A substance P neuronal input onto 
the locus coeruleus cells is considered to be excitatory.
Several authors have found that morphine and the 
endogenous opioids potentiate the effects of neonatal 
treatment with 6-OHDA and 6-0HD0PA. Harston et al. (1981) 
demonstrated that treatment with morphine or naloxone in 
combination with 6-0HD0PA at birth results in increased 
adult NE levels and numbers of NA fibers in the pons- 
medulla and cerebellum. Similar effects were seen with 
8-endorphin, leu- and met-enkephalin, and d-ala - 
enkephalinamide. It was later shown that the morphine and 
6-0HD0PA combination at 3 days after birth resulted in a 
duplication of the findings from treatment at birth, with 
the exception that now the changes were blocked by naloxone, 
also given at 3 days after birth (Kostrzewa and Xlisans-
Fuenmayor, 1984). Jonsson and Hallman (1982a) conducted 
similar studies, administering 6-OHDA and morphine to 
newborn pups. The H-NE uptake velocity in these animals, 
as adults, was significantly reduced in the olfactory bulb 
and frontal cortex and significantly increased in the 
cerebellum. Naloxone administration reversed the effects 
of morphine. Clonidine, another potent inhibitor of locus 
coeruleus activity, administered as above in combination 
with 6-OHDA, produced results similar to that of morphine 
(Bardo et al., 1983). Thus, opioids and other compounds 
that inhibit locus coeruleus activity potentiate the 
decreased NA fiber density in the forebrain, and the 
increased fiber number in the hindbrain following neonatal 
neurotoxin treatment.
Substance P, the peptide with excitatory effects on 
locus coeruleus activity, counteracts the actions produced 
by 6-OHDA (Jonsson and Hallman, 1982c and 1982d). When 
substance P and 6-OHDA were administered at birth, the 
adult NE levels and H-NE uptake rate were increased in the 
frontal and occipital cortex and decreased in the cerebellum 
and pons-medulla. Results similar to these have been found 
with nicotine, a drug also known to alter locus coeruleus 
activity (Jonsson and Hallman, 1980).
Bardo et al. (1983) and Harston et al, (1981) suggest­
ed that the drugs which alter the response of the locus 
coeruleus neurons, do so by modifying or enhancing the 
degenerative response to the neurotoxins; that is, morphine
increases the toxicity of 6-0HD0PA and thus potentiates the 
response of neurons. Another explanation of the opioid 
effects is the "pruning" hypothesis (Jonsson and Hallman/ 
1982a and 1982c and Harston et al., 1982). According to 
this hypothesis, synaptic inputs onto the locus coeruleus 
govern the state of the nuclei at the time of treatment, 
allowing an altered response to the neurotoxins. The inter­
action of opioids with NA fiber development is better 
studied in animals where the NA network has been disrupted 
by a mechanical (non-chemical) means. With this technique 
there are no drug interactions to complicate the study.
This type of damage will produce true pruning; that is, the 
cutting of one branch of fibers produces an outgrowth of 
the other branches. In contrast the neurotoxin treatment 
damages fibers throughout the brain, and this results in an 
outgrowth of some of these fibers. The present study thus 
represents a novel approach to define the role of opioid 
alteration of NA fiber recovery.
Chapter II 
Preliminary Studies
To ascertain the feasibility of the present study 
preliminary work was done. Rats received a bilateral 
lesion at the level of the colliculi at 3 days of age to 
transect the dorsal NA bundles. Immediately prior to the 
cut animals received an injection of saline, morphine, 
naloxone, or a combination of morphine and naloxone. At 
six weeks of age the NE content was determined in the 
cerebellum, pons-medulla, hippocampus, and posterior 
cortex. It was found that animals receiving the neonatal 
lesions had significantly lower NE levels in the hippocampus 
and posterior cortex, and higher levels in the pons-medulla 
and cerebellum. Morphine treatment appeared to attenuate 
this effect in the pons-medulla and cerebellum, while the 
effect of naloxone was unclear. In contrast the NE concen­
tration in the posterior cortex and hippocampus was 
significantly increased with morphine treatment. Naloxone 
administered alone did not vary the NE levels in these areas, 
but it reversed the effects of morphine. In this preliminary 
study morphine treatment in combination with a brainstem 
lesion significantly enhanced recovery of NE in the forebrain.
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CHAPTER III 
Objectives and Proposal
This project is designed to determine whether opioids, 
specifically morphine and met-enkephalin, alter the pattern 
of distribution of noradrenergic fibers in specific brain 
regions, subsequent to a gross surgical lesion encompassing 
the DNB. The hypothesis is that the opioid system does play 
a role in regeneration of noradrenergic fibers after a 
surgical lesion in the brainstem of developing animals.
To demonstrate the effects of morphine and enkephalin on 
noradrenergic regeneration, measurements indicative of 
noradrenergic fiber number will be made in different brain 
regions of adult animals that were treated as neonates. 
Comparison of the test subjects with sham controls will 
provide the test of the hypothesis.
11
CHAPTER IV
Materials and Methods
A. Animals and Treatment
Animals from our colony of Camm-derived Sprague 
Dawley rats were used. Two groups of animals were treated 
at 3 days after birth. In the first group naloxone*HC1 
{2.0 mg/kg) was administered concurrently with saline 
(0.85%) or morphine sulfate (3.33 mg/kg) by the intraperi- 
toneal (i.p.) route (table 1). A second group of rats 
received an i.p. injection of naloxone or saline, 10 
minutes prior to an intraventricular (i.vtr.) injection of 
5 vl of morphine sulfate (10 yg), or methionine-enkephalin 
(25 ug# Behring Diagnostics)# or saline (0.85%) (table 1).
Half the animals treated with the above regimens 
received a surgical lesion, made with a blade 3 mm (depth) 
by 5 mm (width) under ice anesthesia (80 seconds), at the 
level of the colliculi, as illustrated below:
lambda
cerebellui
forebra:
5mm width 3mm depth
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Group 1 Group 2
i.p. A-P- i*P * i.vtr.
Saline + Saline Saline + Saline
Saline + Morphine Saline + Morphine
Naloxone + Saline Saline + Met-Enk
Naloxone + Morphine Naloxone + Saline
Naloxone + Morphine
Naloxone + Met-Enk
Table 1
Animals listed In group 1 received a combination of 
two intraperltoneal (I.p.) Injections of saline, morphine, 
or naloxone, as Indicated. Animals in group 2 were 
injected with naloxone or saline (i.p.), 10 minutes prior 
to an intraventricular (i.vtr.) injection of saline, 
morphine, or met-enkephalin (met-enk), also in the 
combinations indicated.
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The remaining half of the animals were anesthetized on ice, 
but did not receive the surgical lesion. The animals in 
group 1 received one of the injection combinations 
immediately following the surgical lesion. In the second 
group, animals received the i.p. injection 10 minutes prior 
to the i.vtr. injection, and were surgically lesioned 
immediately afterward.
Following treatment, litters were returned to their 
dams and kept in the animal care facilities on a 12 hour 
light/dark day cycle (on 0600) until sacrifice. The pups 
were weaned at 4 weeks, at which time the males and females 
were separated for group housing. All animals were sacri­
ficed at 6 weeks of age unless otherwise indicated.
B. Histochemistry
Noradrenergic fibers were observed histochemically 
with the glyoxylic acid histofluorescence method of de la 
Torre and Surgeon (1976). In this procedure the whole 
brain was removed, mounted, and frozen onto a specimen 
plate. The tissue was then cut in cross sections at 
30 ym in an IEC cryostat. Sectioned tissue from the cortex 
was then thawed onto glass slides and immersed in a glyoxylic 
acid solution (1%) containing sucrose (0.2 M) and potassium 
phosphate (0.236 M). After drying the tissue specimens 
were heated to 80°C for exactly 5 minutes, after which, the 
slides were coverslipped with mineral oil. Sections were 
viewed in an Olympus fluorescence microscope by two
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experienced observers, who were unaware of the treatment 
grouping of each animal, After observation for green 
fluorescent fibers, photomicrographs were taken for a 
permanent record of the observation.
C. Determination of NE Concentration
Biochemical assessment of NA fiber input to the 
various brain regions was made with the trihydroxyindole 
fluorometric method of Hogans (Nagatsu, 1973). The 
cerebellum, pons-medulla, anterior cortex, posterior cortex, 
and hippocampus were dissected at the time of sacrifice, 
frozen on dry ice, and stored at -80°C until the time of 
assay. Dsing this procedure, tissues were homogenized in 
acidified butanol, and HE was extracted into a phosphate 
buffer (pH 6.5), for oxidation to the product, 3,5,6- 
trihydroxyindole, by iodine. The relative amount of 
fluorescent product was then determined in a spectrophoto- 
fluorometer at 385/485 (excitation (nm)/emission (nm)) 
wavelengths. The concentration of NE was expressed as 
nanograms NE per milligram tissue mass.
D. Measurement of ^H-Norepinephrine Optake Rate
The anterior cortex, posterior cortex, and cerebellum 
were dissected at the time of sacrifice and immediately 
homogenized on ice in 10 volumes (weight/volume) of 0.32 M 
sucrose. The homogenate was then centrifuged at 1,000 x g 
for 10 minutes to obtain the supernatent containing synapto- 
somes (Jonsson and Sachs, 1976). Analysis of protein
content was done on an aliquot of supernatent (Lowry et al., 
(1951). Aliquots of the supernatent (125 pi of posterior 
cortex or anterior cortex and 160 yl of cerebellum) were 
preincubated for exactly 5 minutes at 37°C with Krebs-Ringer 
bicarbonate in a total volume of 1.9 ml (pH 7.4 with 0.2 
mg/ml ascorbic acid, 2.41 yg/ml nialamide and saturated 
with 95% 0^  and 5% C02), After addition of 0.1 ml of a 
3H-NE (10 yCi/ml of DL-[7-3H(N)] NE-HC1) and NE*HC1 
(0.05 ym for posterior cortex or anterior cortex and 
0.1 ym for cerebellum) solution, incubation was continued 
for another 5 minutes. The 3H-NE uptake process was 
terminated by addition of 8 ml of cold Krebs-Ringer buffer. 
Samples were spun at 10,000 x g for 10 minutes and the 
supernatent was discarded. Absolute ethanol (1.2 ml) was 
added and the samples were allowed to stand overnight. The 
next day 1 ml of the ethanol containing the extracted radio­
activity was counted in 10 ml scintillation fluid 
(Scintiverse, Fischer) using a Beckman liquid scintillation 
counter. The fmoles NE taken up was calculated by dividing 
the DPM's by the specific activity of the 3h-NE solution.
E. Radioimmunoassay of Met-Enkephalin
A separate group of animals was surgically lesioned, 
as described earlier, at 3 days and sacrificed at 4 or 7 
days after birth. During the dissection the pons-medulla, 
a portion of the pons-medulla containing the locus coeruleus, 
and the posterior cortex was removed. This tissue was then
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stored at -80°C until time of assay.
Tissue was then weighed and heated in 1 M acetic acid 
(200 pi for locus coeruleus and 700 yl for pons-medulla and 
posterior cortex) at 95°C for 15 minutes. The samples were 
chilled^ homogenized by ultrasound (Branson Model W-200 P) 
for 5 seconds/ and after removal of an aliquot for 
protein, were centrifuged at 1,000 x g for 10 minutes. The 
supernatent was transfered to microfuge tubes and vacuum 
centrifuged until dry. The samples were resuspended in 
500 yl of BSA-phosphate buffer with ultra-sound for 5 seconds, 
followed by shaking at 37° for 10 minutes. After centri­
fugation at 10,000 x g each aliquot was appropriately 
diluted with buffer. Met-enkephalin content was measured 
using a radioimmunoassay (RIA) kit from Immuno Nuclear 
Corporation.
P. Statistical Analysis
A 2 x 4 ANOVA was done using the NG content and
3'
H-NE uptake values for the systemic administration of 
opioids. A 2 x 6 ANOVA was used for the data obtained 
after intraventricular administration of drugs. A single 
factor ANOVA and then a Newman-Keuls was used to analyze 
the per cent recovery in the anterior cortex, posterior 
cortex, and hippocampus. A single factor ANOVA was also 
used to compare met-enkephalin content in control and 
lesioned animals in the different areas studied.
Chapter V 
Results
A. Verification of Transection of the Dorsal Bundle
Control and experimental animals receiving a lesion 
at 3 days postnatally were sacrificed at 7 days after birth. 
At this time there was no gross evidence of the lesion. 
However, using the histofluorescence method large numbers 
of brightly fluorescent, swollen and densely packed fibers 
were seen emanating in a rostral direction from the locus 
coeruleus of the animal receiving a lesion (fig. la). This 
contrasted sharply to the fine thin fibrils in the same 
position in control animals (fig. lb). It is generally 
considered that the densely packed fluorescence indicates 
a retrograde accumulation of NE in portions of axonal 
fibers that are proximal to the transection.
B. Systemic Administration of Morphine
In figure 2 the NE concentration and rate of ^H-NE 
taken up in the cerebellum is reported. The neonatal mid­
brain lesion resulted, at six weeks of age, in an increase 
in both parameters in each of the lesion groups. Both NE
3
concentration and H-NE uptake in the cerebellum at 6 weeks 
were not significantly different in any of the drug treat­
ment groups. Similarly in the pons-medulla, the values for
3
NE concentration and H-NE uptake at six weeks were 
significantly increased in the lesion groups. However,
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Figure 1
Photomicrographs of histofluorescent fibers originating 
in the locus coeruleus and traversing rostrally. Sections 
were taken from animals 7 days after birth, following either 
a brainstem lesion at 3 days after birth (a) or anesthesia 
only (b). The bar in (a) indicates 50 tint*

Figure 2
Mean (+SEM) NE concentration (ng/g wet weight) and 
rate of 3H-NE uptake (fmoles/mg protein/5 min) in the 
cerebellum at six weeks after a neonatal midbrain lesion 
and intraperitoneal treatment with a combination of saline/ 
morphine, and naloxone (group 1, N**6-ll).
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there was no significant difference in these parameters 
among the drug treatment groups (fig. 3).
In the anterior and posterior cortex (figs. 4 and 5) 
the lesion produced a dramatic decrease in the development 
of NE concentration and ^H-NE uptake. The different drug 
treatments did not significantly alter either NE concentra- 
tion or H-NE uptake in any of the brain regions of animals 
at 6 weeks after birth. In Figure 6 the NE concentration 
in the hippocampus is illustrated. Within the lesioned 
groups of animals there was a decrease in NE concentration 
in the hippocampus similar to that seen in the cortical 
areas. Analysis of the Anova's on these measurements 
established a significant main effect of the lesion in all 
areas with all measurements, but there was no statistical 
variance with the drug treatments. Therefore, in all brain 
regions studied the measurements for ^H-NE uptake and NE 
concentration were significantly different between sham and 
lesion animals, but within the sham and lesion groups the 
values were not significantly different between the drug 
treatment groups.
C. Intraventricular Administration of Opioids
The values obtained for NE concentrations and rates
3
of H-NE uptake of the animals as adults in group 2 are 
reported in figures 7-14. In these animals that received 
an injection of naloxone prior to an intraventricular 
injection of an opioid (i.e. morphine or met-enkephalin),
Figure 3
Mean (+SEM) NE concentration (ng/g wet weight) in the 
pons-medulla at six weeks after a neonatal midbrain lesion 
and intraperitoneal treatment with a combination of saline, 
morphine, and naloxone (group 1, N=6-12).
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Figure 4
Mean (+SEM) ME concentration (ng/g wet weight, N=6-12) 
and rate of H-NE uptake (fmoles/mg protein/5 min, N=4-7) 
in the anterior cortex at six weeks after a neonatal 
midbrain lesion and intraperitoneal treatment with a 
combination of saline (sal), morphine (mor), and naloxone 
{nalj (group 1).
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Figure 5
Mean (+SEM) ME concentration (ng/g wet weight) and 
rate of H-NE uptake (fmoles/mg protein/5 min) in posterior 
cortex at six weeks after a neonatal midbrain lesion and 
intraperitoneal treatment with a combination of saline 
(sal)/ morphine (mor)/ and naloxone (nal) (group 1/ N=5-10).
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Figure 6
Mean (+SEM) NE concentration (ng/g wet weight) in the 
hippocampus at six weeks after a neonatal midbrain lesion 
and treatment with a combination of saline (sal), morphine 
(mor), and naloxone (nal) (group 1, N=6-12).
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the midbrain lesion produced an increase in the NE concen­
tration of the cerebellum (fig. 7) and pons-medulla (fig.
8). This increase in NE concentration in the cerebellum 
and pons-medulla was similar in all the drug treatment 
groups. The drug treatment groups in these areas all had 
similar values for NE concentration in both the sham and 
lesion animals. In contrast the NE concentration in 
anterior (fig. 9) and posterior (fig. 10) cortex and 
hippocampus (fig. 11) was significantly lower in the groups 
that received a lesion.
3
Similar results were obtained when H-NE uptake was 
studied in the different brain regions of lesioned animals.
In the anterior cortex (fig. 12) there was a significant
3
decrease in the rate of H-NE uptake for those groups 
receiving the cut, but there were no significant changes 
with drug treatment. The variability seen in these measure­
ments is probably not reflective of drug treatment, but due 
to smaller group size (N “ 3-5). Similarly, in the 
posterior cortex (fig. 13) the ^H-NE uptake was signifi­
cantly lower in the lesion groups. However there again 
were no differences between the drug treatment groups. In 
the cerebellum (fig. 14), as in all areas previously report­
ed, there was a significant effect of the lesion using 
ANOVA for the ^H-NE uptake measurements, but the drug 
treatments resulted in no statistical alterations.
In figure 15 NE is expressed as percent of control 
for all the lesion animals in the different forebrain
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Figure 7
Mean (+SEM) NE concentration (ng/g wet weight) in the 
cerebellum of 6 week old animals (group 2) after neonatal 
injections of combinations of naloxone or saline plus 
met-enkephalin (met-enk), or morphine, or saline in 
unoperated sham controls (N=7-9) or animals that received 
a neonatal brainstem lesion (N=10-12).
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Figure 8
Mean (+SEM) NE concentration (ng/g wet weight) in the 
pons-medulla of 6 week old animals (group 2) after neonatal 
injections of combinations of naloxone or saline plus met- 
enkephalin (met-enk), or morphine, or saline in unoperated 
sham controls (N»6-9) or animals that received a neonatal 
brainstem lesion (N«*10-12).
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Figure 9
Mean (+SEM) ME concentration (ng/g wet weight) in the 
anterior cortex of 6 week old animals (group 2) after 
neonatal injections of combinations of naloxone or saline 
plus met-enkephalin (met-enk), or morphine, or saline in 
unoperated sham controls (Na7-9) or animals that received 
a neonatal brainstem lesion (N=8-12).
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Figure 10
Mean (+SEM) NE concentration (ng/g wet weight) in the 
posterior cortex of 6 week old animals (group 2) after 
neonatal injections of combinations of naloxone (nal) or 
saline (sal) plus met-enkephalin (met-enk), or morphine 
(mor), or saline in unoperated sham controls (N=7-9) or 
animals that received a neonatal brainstem lesion 
(N*10-12).
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Figure 11
Mean (+SEMJ NE concentration (ng/g wet weight) in the 
hippocampus of 6 week old animals (group 2) after neonatal 
injections of combinations of naloxone (nal) or saline 
(sal) plus met-enkephalin (met-enk)/ or morphine (mor)/ or 
saline in unoperated sham controls (N=7-9) or animals that 
received a neonatal brainstem lesion (Na9-ll).
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Figure 12
3
Mean (+SEM) rate of H-NE uptake (fmoles/mg protein/
5 min) in the anterior cortex of 6 week old animals (group 
2) after neonatal injections of combinations of naloxone 
or saline plus met-enkephalin (met-enk), or morphine, or 
saline in unoperated sham controls (N=3-7) or animals that 
received a neonatal brainstem lesion (N=3-5).
44
ANTERIOR CORTEX
Saline
M et-Enk
Morphine
Naloxone
Naloxone + M et-Enk — —i
Naloxone+M orphine  1
□  s h a m
.....J
LESION
1 .5 0  2 .0 0  2 .5 0  3 .0 0  3 .5 0
3 H-NE uptake (f m oles/m g/5 min)
45
Figure 13
3
Mean (+SEM) rate of H-NE uptake (fmoles/mg protein/
5 min) in the posterior cortex of 6 week old animals (group 
2) after neonatal injections of combinations of naloxone 
or saline plus met-enkephalin (met-enk), or morphine, or 
saline in unoperated sham controls (N=4-8) or animals that 
received a neonatal brainstem lesion (N=6-10). *
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Figure 14
Mean (+SEM) rate of ^H-NE uptake (fmoles/mg protein/
5 min) in the cerebellum of 6 week old animals (group 2) 
after neonatal injections of combinations of naloxone 
or saline plus met-enkephalin (met-enk), or morphine, or 
saline in unoperated sham controls (N*4-8) or animals that 
received a neonatal brainstem lesion (N=6-10).
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Figure 15
Mean NE concentration (ng/g wet weight# percent of 
unoperated controls) in different forebrain areas of 6 
week old animals that received a neonatal brainstem lesion 
(N=61-63). There is a significant difference {p <0*05) 
between each region.
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regions. The NE concentration of the lesloned animals In 
the anterior cortex was 39% of the control animals, while 
the posterior cortex was 27% of control, and significantly 
different from that In the anterior cortex. The lowest 
content of NE was found in the hippocampus, at 21% of 
control, and this was significantly different from that in 
either area of the cortex.
D. Met-Enkephalin Levels
There was no difference In met-enkephalin concen­
tration, when expressed in terms of weight of the tissue, 
between the lesion and the control animals at 1 and 4 days 
after the lesion in any of the regions studied (table 2). 
Table 3 represents an expression of the met-enkephalin 
concentration per milligram of protein. On this basis 
there was a significant difference between the control and 
lesloned animals in the locus coeruleus region 1 day after 
the lesion. At this time point the lesion group had higher 
levels of met-enkephalin, but at 4 days after the lesion 
there was no longer a difference between the groups.
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Area Days Ebst-lesion 
1 day 4 days
Control Lesion Control Lesion
locus
Coeruleus
Region
165.76 ± 26.4* 190.65 ± 27.1 220.93 ± 41.7 258.64 ± 52.8
Ebns-
Medulla 412.83 ± 44.5 425.88 ± 34.3 589.65 + 29.8 652.48 ± 54.7
Posterior
Cortex 72.61 ± 3.9 61.42 ± 12.1 83.67 ± 5.1 118.16 ± 16.1
♦Mean ± SEM
Table 2
Met-enkephalin content (ng/mg tissue weight) in 
various brain regions of rats, 1 and 4 days after a 
dorsal bundle lesion made at 3 days after birth.
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Area Days Post-lesion 
1 day 4 days
Control Lesion Control Lesion
locus
Coeruleus
Region
1.69 ± 0.34* 3.01 ± 0.34** 3.54 ± 0.48 3.09 ± 0.44
Ebns-
Medulla 8.06 1 0.81 7.88 ± 0.68 11.36 i 0.36 12.36 ±1.13
Posterior
Cortex 1.72 ± 0.12 1.35 ± 0.27 1.67 ± 0.15 2.34 ± 0.29
*Mean ± SEM 
**p < 0.05
Table 3
Met-enkephalin concentration (ng/mg protein) in 
various brain regions of rats, 1 and 4 days after a 
dorsal bundle lesion made at 3 days after birth.
Chapter VI 
Discussion
A. Opioid Effects on Noradrenergic Neurons
Neonatal treatment with morphine# met-enkephalin, or
naloxone had no effect on NA fiber number in the brains of
sham control rats at six weeks after birth. Within the
sham groups there was no difference between the assorted
drug treatments. In the animals that received a DNB lesion,
there was also no difference among the drug treatment groups,
in NE concentration and 3H-NE uptake in the forebrain or
hindbrain regions. The measurements of NE concentration 
3
and H-NE uptake taken together are a good indication of 
NA nerve terminal density (Jonsson and Sachs, 1982). The 
surgical axotomy produced the expected increases in NA 
fiber number in the brainstem and cerebellum, and decreases 
in fiber number in the forebrain regions.
The previous findings, that morphine attenuated the NA 
effects associated with a DNB lesion, implied that in the 
present study the opioids would alter recovery of the NA 
fibers. Bardo et al. (1983) also found that morphine 
administration with a midcollicular hemisection reduced 
collateral sprouting in the ipsilateral cerebellar hemi­
sphere, results similar to the preliminary study. Earlier 
studies with morphine and 6-0HD0PA, demonstrating that 
morphine potentiated the effects of neonatal neurotoxin 
treatment (Harston et al., 1981 and Jonsson and Hallman,
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1982a), also suggested an opioid Involvement In developmental 
recovery. Since recovery from neurotoxin and surgical 
axotomy is very similar, morphine was expected to alter 
the recovery from both manipulations. Further support for 
this hypothesis came from a report by Jonsson and Hallman 
(1983), in which substance P administration after unilateral 
transection of the DNB resulted in significant increases in 
NA fiber number in the cerebellum and pons-*medulla.
Substance P in that study did not counteract the damage 
in the cortex, but was effective in altering recovery of 
NA fibers in some areas.
The results of the preliminary study are considered to 
be unreliable, because of the large amount of variability 
in the lesion groups. The variability may have been the 
result of inconsistent transection of the DNB neonatally.
If the lesion were not successful, the adult values 
obtained would be identical to that of the controls 
and thus inaccurately representing recovery. In the 
present study the surgical axotomy was considered to be 
successful. The ANOVAs on all the areas studied with all 
the different treatments demonstrated a significant main 
effect of the lesion. Also, the large number of animals 
surgically treated, has produced more consistent results.
Thus in this study the large variability within the lesion 
groups was not present. The success of the lesion was 
verified in some animals by examining the fibers projecting 
from the locus coeruleus four days after the lesion. An
accumulation of NE was seen, indicating the fibers were 
cut. In these animals there was no visible clotting or 
scarring at the lesion site. Immunocytochemical locali­
zation of glial fibrillary acidic protein, a m a r k e r for 
glia, was used to study the glia after a neonatal brain­
stem lesion. An accumulation of the acidic protein 
indicates scarring has taken place. Examination of the 
distribution of the glial fibrillary acidic protein in the 
area of the lesion at six weeks revealed no accumulation 
of this protein and thus no scarring {unpublished results). 
Some of the values for NE content and H-NE uptake, obtained 
for the lesioned animals, were closer to control, and thus 
suggested a degree of recovery of the NA fibers in these 
animals. Approximately one of eight surgically treated 
animals demonstrated this recovery, possibly indicating a 
percentage of unsuccessful cuts. However, in the prelimi­
nary study the frequency of these unusual animals may have 
been greater than in the present study.
Bardo et al. (1983) found that morphine administration 
with a unilateral lesion of the DNB reduced the sprouting 
in the ipsilateral cortex. These results have never been 
published completely. Thus the details of the study are not 
available. This group used a unilateral lesion in their 
study compared to a bilateral cut in the present study.
The conflicting results in the two studies could be 
explained, if the lesion values obtained in the unilateral 
study were compared to values obtained from the
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contralateral side rather than control animals. Bardo et al. 
(1983) also only mentioned effects in the cerebellum with no 
information about the changes in the cortex.
Jonsson and Hallman (1983) also used a unilateral lesion 
to show that substance P produced an alteration in nora­
drenergic fiber recovery only in the hindbrain regions and 
not in the cortical areas. In the previous work with 
neurotoxins, substance P could potentially modify recovery 
of all of the projections of the locus coeruleus. The 
authors suggest that the substance P alterations may be 
due to a growth-promoting effect of the compound in specific 
areas and thus not a general effect on the locus coeruleus 
to direct growth.
In contrast to those findings with neurotoxins, it is 
now reported that opioids do not have an effect on recovery 
of a NA system damaged by surgical axotomy. Because opioids 
do modify recovery of NA fibers damaged by the neurotoxin, 
6-0HD0PA (Harston et al., 1981), the present study indicates 
that this action probably results from a modification of the 
neurotoxic actions of the 6-0HD0PA. Failure of the opioids 
to modify recovery of NA fibers from a mechanical lesion 
suggests that the opioids are not capable of acting on the 
NA fibers to actually stimulate regeneration. Procedurally, 
neurotoxins damage all major projections of the locus 
coeruleus, by being taken up into the nerve terminal areas 
and destroying these regions. The surgical axotomy severs 
the connections of the locus coeruleus to the forebrain
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projections only. The DNB lesion severs the neurons in 
only one major bundle. Opioids may be effective in altering 
nerve terminal input, but not in promoting major nerve fiber 
connections.
Previous work in our laboratory has established that 
neonatal 6-0HD0PA treatment (the same protocol as in the 
neurotoxin studies) does not alter the number of cells in 
the locus coeruleus (unpublished results). In a similar 
study with animals in which the DNB had been transected 
neonatally, the number of cells in the locus coeruleus was 
found to be decreased (Kostrzewa et al., 1985). The damage 
produced by transection of the DNB is thus very different 
from the neurotoxin damage.
The evidence suggests that opioid alterations are 
specific for neurotoxin induced damage. This may be a 
consequence of the opioids interacting with or combining 
with 6-OHDOPA, although there is no evidence at present 
for this. The drugs are toxic to the neurons and the 
opioids may also be toxic or just capable of enhancing the 
toxicity of the neurotoxins.
The "pruning effect," proposed by Jonsson and Hallman 
(1982a and b), suggests that nerve terminals are programmed 
to develop a certain number of arborizations to each of the 
target areas of the locus coeruleus. Following damage to 
one projection the neurons would develop an enhanced nerve 
terminal arborization in an intact collateral region. The 
synaptic inputs onto the locus coeruleus were thought to
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influence this response to damage of the nuclei. Exogenous 
administration of opioids did not alter the response of the 
nuclei to surgical axotomy; opioids, therefore, are not 
working at the level of the perikarya, when altering the 
recovery from neurotoxin damage. The present study demon­
strates that opioids do not alter true pruning, but rather 
alter recovery from nerve terminal damage as in the 
neurotoxin treated animals.
B. Met-Enkephalin Concentration in Neonatal Animals with
a Severed Dorsal Noradrenergic Bundle
The animals that received the DNB lesion exhibited an 
increase in met-enkephalin levels in the locus coeruleus 
region, one day after the lesion. This result could 
indicate an increased met-enkephalin fiber activity, as a 
consequence to NA fiber injury. The effect was immediate, 
but not prolonged, since met-enkephalin content was not 
elevated four days after the lesion. The validity of this 
result is questionable, because an effect was not present 
when the met-enkephalin concentration was expressed in 
terms of tissue weight.
Additional studies would need to be done to clarify 
these results. Moreover, the locus coeruleus would need to 
be more discretely dissected in order to obtain a greater 
reliability of such findings. Either biochemical measure­
ments of met-enkephalin with micropunch samples would be 
suitable, or immunocytochemical quantitative histochemistry
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of met-enkephalin fibers in the locus coeruleus. More 
frequent sampling would show the time course of any changes 
in the met-enkephalin fibers resulting from NA fiber tran­
section. Although met-enkephalin levels may increase with 
damage to the neurons, as indicated in this portion of the 
study, exogenous administration of met-enkephalin did not 
produce any apparent alteration in the recovery of locus 
coeruleus fibers.
C. Noradrenergic Recovery from a Dorsal Bundle Lesion 
The DNB lesion was found to reduce NE content and
3
H-NE uptake in brain regions distal to the fiber transec­
tion (i.e. neocortex and hippocampus). At the same time a 
retrograde degeneration occurs in at least a portion of 
those fibers that were transected. Upon studying the 
recovery of the forebrain projections, it has been noted 
that NA fiber recovery in the anterior cortex recovered to 
a greater degree than was found in the posterior cortex. 
Recovery was least in the hippocampus.
The pattern of recovery suggests that './A fiber 
recovery is greater when axonal fiber length to a target 
area is short. A long axonal fiber length may result in 
fewer axons being able to regenerate across the longer 
fiber pathway. Because the degree of recovery of NA fibers 
was identical in each of the target regions at both 4 and 6 
weeks, the recovery pattern appears to be permanent once 
an animal reaches adulthood.
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D. Summary
Neither morphine nor met-enkephalin administration 
alters the recovery of NA fibers in various rat brain regions 
after a mechanical lesion of the DNB. The opioid system does 
not seem to play a role in regeneration of NA fibers after a 
surgical lesion in the brainstem of developing animals. 
Previous studies, using neurotoxins to produce damage, 
suggested that the opioid system was capable of altering 
the NA fiber development after damage to the system neo­
natal ly. The present studies indicate that the opioid 
system does not have a growth promoting effect on NA 
recovery from degeneration produced by a DNB cut, but that 
the specific opioid compounds are only effective in 
n eurotoxin-indueed degeneration.
A regional difference in recovery of the NA fibers 
after neonatal axonal transection has been noted. The 
present findings demonstrate that the degree of recovery 
of central NA fibers is related to the length of the 
axonal pathways. The distance the terminal areas are from 
the locus coeruleus seems to determine the amount of 
recovery.
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